Understanding Angelman Syndrome - Enhancing Lives Through Awareness
Angelman syndrome is a rare genetic condition impacting physical milestones and learning abilities. It affects around 1 in 15,000 individuals globally, with symptoms including speech difficulties, disrupted sleep, and seizures. Though there is no cure, increased awareness and research provide hope for treatments to improve the quality of life for those with Angelman syndrome.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
E N D
Presentation Transcript
ABOUT ANGELMAN SYNDROME Angelman syndrome is a genetic condition that can cause physical and learning disabilities.
ABOUT ANGELMAN SYNDROME Angelman syndrome is rare and affects roughly 1 in 15,000 people.
ABOUT ANGELMAN SYNDROME There are approximately 500,000 individuals globally living with Angelman syndrome.
ABOUT ANGELMAN SYNDROME Symptoms of Angelman syndrome include learning and speech difficulties, problems with balance and movement, disrupted sleep and seizures.
ABOUT ANGELMAN SYNDROME Other characteristics associated with Angelman syndrome include frequent laughing and smiling, being easily over-excited, and a fascination with water.
ABOUT ANGELMAN SYNDROME The life expectancy of people with Angelman syndrome is normal.
ABOUT ANGELMAN SYNDROME Individuals living with Angelman syndrome are universally unable to speak vocally but they have a LOT to say!
ABOUT ANGELMAN SYNDROME Most of those with Angelman syndrome will require significant lifelong support.
ABOUT ANGELMAN SYNDROME Angelman syndrome is caused by problems with a gene located on chromosome 15, called the UBE3A gene.
ABOUT ANGELMAN SYNDROME Currently, there is no cure for Angelman syndrome.
ABOUT ANGELMAN SYNDROME With increased awareness and research, there is hope for treatments to enhance the lives of individuals with Angelman syndrome.
ABOUT FAST The Foundation for Angelman Syndrome Therapeutics (FAST) is dedicated to finding a cure for Angelman syndrome for all individuals, regardless of age or genotype, by identifying and funding translational research leading to transformative therapeutics enabling all individuals to realize their full potential and quality of life.
ABOUT FAST FAST has affiliates in Latin America, Australia, Canada, Colombia, France, Italy, Spain, and the UK.
ABOUT FAST Over 90% of every dollar donated to FAST supports critical research.
ABOUT FAST FAST launched in 2008. Since then, FAST has invested over $25 million to help bring transformative therapeutics to humans living with AS.
ABOUT FAST FAST has funded 10 gene therapy/disease modification-based programs to support drug development for Angelman syndrome.
ABOUT FAST 15 of the 33 potential Angelman syndrome therapeutics in the pipeline Are robustly funded by FAST.
ABOUT FAST FAST funds over 20 academic research laboratories to understand the etiology and identify treatment options for Angelman syndrome.
ABOUT FAST FAST has directed over $3 million to create novel animal models of Angelman syndrome.
ABOUT FAST FAST is a leading innovator in rare disease research and launched a biotech company to advance the first disease modifying therapy into a human clinical trial.
